<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-04-16" modified="2020-10-07" version="183">
<accession>O14543</accession>
<accession>O14509</accession>
<name>SOCS3_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="14">Suppressor of cytokine signaling 3</fullName>
<shortName>SOCS-3</shortName>
</recommendedName>
<alternativeName>
<fullName>Cytokine-inducible SH2 protein 3</fullName>
<shortName>CIS-3</shortName>
</alternativeName>
<alternativeName>
<fullName>STAT-induced STAT inhibitor 3</fullName>
<shortName>SSI-3</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="15">SOCS3</name>
<name type="synonym">CIS3</name>
<name type="synonym">SSI3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Biochem. Biophys. Res. Commun." volume="237" first="79" last="83">
<title>Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3.</title>
<authorList>
<person name="Minamoto S."/>
<person name="Ikegame K."/>
<person name="Ueno K."/>
<person name="Narazaki M."/>
<person name="Naka T."/>
<person name="Yamamoto H."/>
<person name="Matsumoto T."/>
<person name="Saito H."/>
<person name="Hosoe S."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="9266833"/>
<dbReference type="DOI" id="10.1006/bbrc.1997.7080"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT TYR-125</scope>
<source>
<tissue>T-cell lymphoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Biochem. Biophys. Res. Commun." volume="239" first="439" last="446">
<title>Cloning and characterization of novel CIS family genes.</title>
<authorList>
<person name="Masuhara M."/>
<person name="Sakamoto H."/>
<person name="Matsumoto A."/>
<person name="Suzuki R."/>
<person name="Yasukawa H."/>
<person name="Mitsui K."/>
<person name="Wakioka T."/>
<person name="Tanimura S."/>
<person name="Sasaki A."/>
<person name="Misawa H."/>
<person name="Yokouchi M."/>
<person name="Ohtsubo M."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="9344848"/>
<dbReference type="DOI" id="10.1006/bbrc.1997.7484"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="278" first="38" last="43">
<title>Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.</title>
<authorList>
<person name="Dey B.R."/>
<person name="Furlanetto R.W."/>
<person name="Nissley P."/>
</authorList>
<dbReference type="PubMed" id="11071852"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3762"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Genes Cells" volume="4" first="339" last="351">
<title>Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.</title>
<authorList>
<person name="Sasaki A."/>
<person name="Yasukawa H."/>
<person name="Suzuki A."/>
<person name="Kamizono S."/>
<person name="Syoda T."/>
<person name="Kinjyo I."/>
<person name="Sasaki M."/>
<person name="Johnston J.A."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="10421843"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.1999.00263.x"/>
</citation>
<scope>INTERACTION WITH JAK2</scope>
<scope>MUTAGENESIS OF LEU-22; PHE-25; GLU-30; TYR-31; VAL-34; LEU-41; GLY-45 AND ARG-71</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Eur. J. Biochem." volume="269" first="2516" last="2526">
<title>A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.</title>
<authorList>
<person name="Hoertner M."/>
<person name="Nielsch U."/>
<person name="Mayr L.M."/>
<person name="Heinrich P.C."/>
<person name="Haan S."/>
</authorList>
<dbReference type="PubMed" id="12027890"/>
<dbReference type="DOI" id="10.1046/j.1432-1033.2002.02916.x"/>
</citation>
<scope>INTERACTION WITH EPOR</scope>
<scope>MUTAGENESIS OF GLY-53; LEU-58; LEU-93 AND ARG-94</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="310" first="1188" last="1193">
<title>SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit.</title>
<authorList>
<person name="Yamamoto K."/>
<person name="Yamaguchi M."/>
<person name="Miyasaka N."/>
<person name="Miura O."/>
</authorList>
<dbReference type="PubMed" id="14559241"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.09.140"/>
</citation>
<scope>INTERACTION WITH IL12RB2</scope>
<scope>MUTAGENESIS OF ARG-71</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Blood" volume="103" first="2997" last="3004">
<title>Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation.</title>
<authorList>
<person name="Okamura A."/>
<person name="Iwata N."/>
<person name="Nagata A."/>
<person name="Tamekane A."/>
<person name="Shimoyama M."/>
<person name="Gomyo H."/>
<person name="Yakushijin K."/>
<person name="Urahama N."/>
<person name="Hamaguchi M."/>
<person name="Fukui C."/>
<person name="Chihara K."/>
<person name="Ito M."/>
<person name="Matsui T."/>
</authorList>
<dbReference type="PubMed" id="15070676"/>
<dbReference type="DOI" id="10.1182/blood-2003-08-2768"/>
</citation>
<scope>INTERACTION WITH CSNK1E</scope>
<scope>PROTEIN STABILIZATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="3055" last="3065">
<title>VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.</title>
<authorList>
<person name="Kamura T."/>
<person name="Maenaka K."/>
<person name="Kotoshiba S."/>
<person name="Matsumoto M."/>
<person name="Kohda D."/>
<person name="Conaway R.C."/>
<person name="Conaway J.W."/>
<person name="Nakayama K.I."/>
</authorList>
<dbReference type="PubMed" id="15601820"/>
<dbReference type="DOI" id="10.1101/gad.1252404"/>
</citation>
<scope>FUNCTION IN AN E3 UBIQUITIN-PROTEIN LIGASE COMPLEX</scope>
<scope>INTERACTION WITH CUL5; RNF7; ELOB AND ELOC</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Am. J. Hum. Genet." volume="78" first="1060" last="1065">
<title>Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis.</title>
<authorList>
<person name="Ekelund E."/>
<person name="Saeaef A."/>
<person name="Tengvall-Linder M."/>
<person name="Melen E."/>
<person name="Link J."/>
<person name="Barker J."/>
<person name="Reynolds N.J."/>
<person name="Meggitt S.J."/>
<person name="Kere J."/>
<person name="Wahlgren C.-F."/>
<person name="Pershagen G."/>
<person name="Wickman M."/>
<person name="Nordenskjoeld M."/>
<person name="Kockum I."/>
<person name="Bradley M."/>
</authorList>
<dbReference type="PubMed" id="16685656"/>
<dbReference type="DOI" id="10.1086/504272"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN ATOPIC DERMATITIS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="380" last="387">
<title>Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.</title>
<authorList>
<person name="Ben-Zvi T."/>
<person name="Yayon A."/>
<person name="Gertler A."/>
<person name="Monsonego-Ornan E."/>
</authorList>
<dbReference type="PubMed" id="16410555"/>
<dbReference type="DOI" id="10.1242/jcs.02740"/>
</citation>
<scope>INTERACTION WITH FGFR3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="39800" last="39811">
<title>Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components.</title>
<authorList>
<person name="Lee K.H."/>
<person name="Biswas A."/>
<person name="Liu Y.J."/>
<person name="Kobayashi K.S."/>
</authorList>
<dbReference type="PubMed" id="23019338"/>
<dbReference type="DOI" id="10.1074/jbc.m112.410027"/>
</citation>
<scope>INTERACTION WITH NOD2</scope>
</reference>
<comment type="function">
<text evidence="2 9">SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS3 is involved in negative regulation of cytokines that signal through the JAK/STAT pathway. Inhibits cytokine signal transduction by binding to tyrosine kinase receptors including IL6ST/gp130, LIF, erythropoietin, insulin, IL12, GCSF and leptin receptors. Binding to JAK2 inhibits its kinase activity and regulates IL6 signaling. Suppresses fetal liver erythropoiesis. Regulates onset and maintenance of allergic responses mediated by T-helper type 2 cells (By similarity). Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15601820).</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="2 5 6 7 8 9 10 12">Interacts with multiple activated proteins of the tyrosine kinase signaling pathway including IGF1 receptor, insulin receptor and JAK2. Binding to JAK2 is mediated through the KIR and SH2 domains to a phosphorylated tyrosine residue within the JAK2 JH1 domain (PubMed:10421843). Binds specific activated tyrosine residues of the leptin, EPO, IL12, GSCF and gp130 receptors (PubMed:12027890, PubMed:14559241). Interaction with CSNK1E stabilizes SOCS3 protein (PubMed:15070676). Component of the probable ECS(SOCS3) E3 ubiquitin-protein ligase complex which contains CUL5, RNF7/RBX2, Elongin BC complex and SOCS3 (PubMed:15601820). Interacts with CUL5, RNF7, ELOB and ELOC (PubMed:15601820). Interacts with CUL2 (PubMed:15601820). Interacts with FGFR3 (PubMed:16410555). Interacts with INSR (By similarity). Interacts with BCL10; this interaction may interfere with BCL10-binding with PELI2 (By similarity). Interacts with NOD2 (via CARD domain); the interaction promotes NOD2 degradation (PubMed:23019338).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-10181113">
<id>Q8N8K9</id>
<label>KIAA1958</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-2133734">
<id>Q66K74</id>
<label>MAP1S</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-10181089">
<id>I6L996</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-1045459">
<id>O95863</id>
<label>SNAI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-7877438">
<id>P42681</id>
<label>TXK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-714146">
<id>O14543</id>
</interactant>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="tissue specificity">
<text>Widely expressed with high expression in heart, placenta, skeletal muscle, peripheral blood leukocytes, fetal and adult lung, and fetal liver and kidney. Lower levels in thymus.</text>
</comment>
<comment type="domain">
<text>The ESS and SH2 domains are required for JAK phosphotyrosine binding. Further interaction with the KIR domain is necessary for signal and kinase inhibition.</text>
</comment>
<comment type="domain">
<text evidence="1">The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin ligase complexes.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated on tyrosine residues after stimulation by the cytokines, IL-2, EPO or IGF1.</text>
</comment>
<comment type="disease">
<text evidence="11">There is some evidence that SOCS3 may be a susceptibility gene for atopic dermatitis linked to 17q25. SOCS3 messenger RNA is significantly more highly expressed in skin from patients with atopic dermatitis than in skin from healthy controls. Furthermore, a genetic association between atopic dermatitis and a haplotype in the SOCS3 gene has been found in two independent groups of patients.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SOCS3ID44124ch17q25.html"/>
</comment>
<dbReference type="EMBL" id="AB004904">
<property type="protein sequence ID" value="BAA22430.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB006967">
<property type="protein sequence ID" value="BAA22537.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF159854">
<property type="protein sequence ID" value="AAD42231.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC060858">
<property type="protein sequence ID" value="AAH60858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11756.1"/>
<dbReference type="PIR" id="JC5627">
<property type="entry name" value="JC5627"/>
</dbReference>
<dbReference type="PIR" id="JC5761">
<property type="entry name" value="JC5761"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003946.3">
<property type="nucleotide sequence ID" value="NM_003955.4"/>
</dbReference>
<dbReference type="BMRB" id="O14543"/>
<dbReference type="BioGRID" id="114488">
<property type="interactions" value="83"/>
</dbReference>
<dbReference type="CORUM" id="O14543"/>
<dbReference type="IntAct" id="O14543">
<property type="interactions" value="57"/>
</dbReference>
<dbReference type="MINT" id="O14543"/>
<dbReference type="STRING" id="9606.ENSP00000330341"/>
<dbReference type="iPTMnet" id="O14543"/>
<dbReference type="PhosphoSitePlus" id="O14543"/>
<dbReference type="BioMuta" id="SOCS3"/>
<dbReference type="EPD" id="O14543"/>
<dbReference type="MassIVE" id="O14543"/>
<dbReference type="PaxDb" id="O14543"/>
<dbReference type="PeptideAtlas" id="O14543"/>
<dbReference type="PRIDE" id="O14543"/>
<dbReference type="ProteomicsDB" id="48078"/>
<dbReference type="Antibodypedia" id="3206">
<property type="antibodies" value="782 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9021"/>
<dbReference type="Ensembl" id="ENST00000330871">
<property type="protein sequence ID" value="ENSP00000330341"/>
<property type="gene ID" value="ENSG00000184557"/>
</dbReference>
<dbReference type="GeneID" id="9021"/>
<dbReference type="KEGG" id="hsa:9021"/>
<dbReference type="CTD" id="9021"/>
<dbReference type="DisGeNET" id="9021"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000184557.4"/>
<dbReference type="GeneCards" id="SOCS3"/>
<dbReference type="HGNC" id="HGNC:19391">
<property type="gene designation" value="SOCS3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000184557">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SOCS3"/>
<dbReference type="MIM" id="604176">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O14543"/>
<dbReference type="OpenTargets" id="ENSG00000184557"/>
<dbReference type="PharmGKB" id="PA134885765"/>
<dbReference type="eggNOG" id="KOG4566">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159620"/>
<dbReference type="HOGENOM" id="CLU_079452_3_0_1"/>
<dbReference type="InParanoid" id="O14543"/>
<dbReference type="KO" id="K04696"/>
<dbReference type="OMA" id="PKRTYYI"/>
<dbReference type="OrthoDB" id="1135696at2759"/>
<dbReference type="PhylomeDB" id="O14543"/>
<dbReference type="TreeFam" id="TF321368"/>
<dbReference type="PathwayCommons" id="O14543"/>
<dbReference type="Reactome" id="R-HSA-1059683">
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877312">
<property type="pathway name" value="Regulation of IFNG signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849474">
<property type="pathway name" value="PTK6 Activates STAT3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939242">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of keratinocytes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951664">
<property type="pathway name" value="Neddylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912694">
<property type="pathway name" value="Regulation of IFNA signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SignaLink" id="O14543"/>
<dbReference type="SIGNOR" id="O14543"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="9021">
<property type="hits" value="96 hits in 869 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SOCS3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SOCS3"/>
<dbReference type="GenomeRNAi" id="9021"/>
<dbReference type="Pharos" id="O14543">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O14543"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="O14543">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000184557">
<property type="expression patterns" value="Expressed in mucosa of stomach and 221 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O14543">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O14543">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005942">
<property type="term" value="C:phosphatidylinositol 3-kinase complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046935">
<property type="term" value="F:1-phosphatidylinositol-3-kinase regulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004860">
<property type="term" value="F:protein kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060670">
<property type="term" value="P:branching involved in labyrinthine layer morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990830">
<property type="term" value="P:cellular response to leukemia inhibitory factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046627">
<property type="term" value="P:negative regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046426">
<property type="term" value="P:negative regulation of receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042532">
<property type="term" value="P:negative regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046854">
<property type="term" value="P:phosphatidylinositol phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060674">
<property type="term" value="P:placenta blood vessel development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045597">
<property type="term" value="P:positive regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060334">
<property type="term" value="P:regulation of interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060708">
<property type="term" value="P:spongiotrophoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060707">
<property type="term" value="P:trophoblast giant cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd10384">
<property type="entry name" value="SH2_SOCS3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR028414">
<property type="entry name" value="SOCS3"/>
</dbReference>
<dbReference type="InterPro" id="IPR035863">
<property type="entry name" value="SOCS3_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001496">
<property type="entry name" value="SOCS_box"/>
</dbReference>
<dbReference type="InterPro" id="IPR036036">
<property type="entry name" value="SOCS_box-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10155:SF11">
<property type="entry name" value="PTHR10155:SF11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00253">
<property type="entry name" value="SOCS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00969">
<property type="entry name" value="SOCS_box"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF158235">
<property type="entry name" value="SSF158235"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50225">
<property type="entry name" value="SOCS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-0582">Pharmaceutical</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0734">Signal transduction inhibitor</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Suppressor of cytokine signaling 3" id="PRO_0000181243">
<location>
<begin position="1"/>
<end position="225"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="3">
<location>
<begin position="46"/>
<end position="142"/>
</location>
</feature>
<feature type="domain" description="SOCS box" evidence="4">
<location>
<begin position="177"/>
<end position="224"/>
</location>
</feature>
<feature type="region of interest" description="Kinase inhibitory region (KIR)">
<location>
<begin position="22"/>
<end position="33"/>
</location>
</feature>
<feature type="region of interest" description="Extended SH2 subdomain (ESS)">
<location>
<begin position="34"/>
<end position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1061489." id="VAR_030033" evidence="13">
<original>H</original>
<variation>Y</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO-induced STAT5 signaling suppression." evidence="5">
<original>L</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO-induced STAT5 signaling suppression. No suppression of JAK2 phosphorylation." evidence="5">
<original>L</original>
<variation>D</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO-induced STAT5 signaling suppression. Abolishes binding to JH1." evidence="5">
<original>F</original>
<variation>A</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of EPO-induced STAT5 signaling suppression. No effect on LIF-induced signaling suppression. Abolishes binding to JH1. Inhibits JAK2 phosphorylation." evidence="5">
<original>E</original>
<variation>R</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO-induced STAT5 signaling suppression. No effect on LIF-induced STAT3 signaling. Abolishes binding to JH1." evidence="5">
<original>Y</original>
<variation>A</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO-induced signaling suppression." evidence="5">
<original>Y</original>
<variation>F</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO/LIF-induced signaling suppression." evidence="5">
<original>V</original>
<variation>E</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO/LIF-induced signaling inhibition. Abolishes binding to JH1." evidence="5">
<original>L</original>
<variation>R</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little effect on EPO/LIF signaling." evidence="5">
<original>G</original>
<variation>A</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on binding to Y429/Y431 phosphorylated EPOR." evidence="6">
<original>G</original>
<variation>V</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to Y429/Y431 phosphorylated EPOR." evidence="6">
<original>L</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of EPO/LIF-induced signaling suppression. No inhibition of JAK2 phosphorylation." evidence="5 7">
<original>R</original>
<variation>E</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on EPO/LIF-induced signaling suppression. Partial suppression of JAK2 phosphorylation. No effect on binding to JH1. Loss of binding to IL12RB2." evidence="5 7">
<original>R</original>
<variation>K</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to Y429/Y431 phosphorylated EPOR." evidence="6">
<original>L</original>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impaired binding to Y429/Y431 phosphorylated EPOR." evidence="6">
<original>R</original>
<variation>E</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA22430." ref="1" evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35718"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00194"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10421843"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12027890"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14559241"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15070676"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15601820"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16410555"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16685656"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23019338"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9266833"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000305"/>
<evidence key="15" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:19391"/>
</source>
</evidence>
<sequence length="225" mass="24770" checksum="08581DC411EFFF19" modified="1998-01-01" version="1">MVTHSKFPAAGMSRPLDTSLRLKTFSSKSEYQLVVNAVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRHFFTLSVKTQSGTKNLRIQCEGGSFSLQSDPRSTQPVPRFDCVLKLVHHYMPPPGAPSFPSPPTEPSSEVPEQPSAQPLPGSPPRRAYYIYSGGEKIPLVLSRPLSSNVATLQHLCRKTVNGHLDSYEKVTQLPGPIREFLDQYDAPL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

